Abstract
Introduction
The efficacy and safety of intensive chemotherapy for patients with hematological malignancies, i.e., malignant lymphoma and leukemia, has been established. However, there are some adverse effects associated with its use. Leukoencephalopathy is a rare but well-known complication of the intensive chemotherapy in such patients. Recently, reports on chemotherapy-induced, or "toxic" leukoencephalopathy have increased (1) (2) (3) (4) (5) (6) (7) (8) (2, 3, 5, 6, 8) Fig. 2A- (9, 10 (1, 3, 6, 8) , other agents, including 5-fluorouracil and its derivative carmofur, and monoclonal antibodies have also been reported to cause the neurotoxicity (12, 13) . Although patients with acute lymphoblastic leukemia seem to be most susceptible to toxic leukoencephalopathy (14, 15) , those with NHL may also suffer from the complication (16) . Recently, reports on toxic leukoencephalopathy have (6, 7) . The subtype has been termed disseminated necrotizing leukoencephalopathy (6, 7) .
. Magnetic resonance imaging (MRI) of the brain is the imaging modality of choice for the differential diagnosis of white matter lesions that develop in patients with hematological malignancies

. Biopsy of the white matter lesions, which is performed less frequently nowadays, is still important because the white matter lesions may be associated with an unexpected etiology. We present a case of gliomatosis cerebri (GC) manifesting as progressive multifocal white matter lesions that developed in an elderly man who had been treated for cervical non-
Hodgkin's lymphoma (NHL).
Case Report
E). The lesions were depicted as mixed intensity on diffusion-weighted imaging (DWI) and high intensity on apparent diffusion coefficient (ADC) map (Fig. 2E). Since the rapid worsening of his condition was considered unusual for toxic leukoencephalopathy which is generally self-limited, and since non-invasive methods alone seemed to be insufficient for establishing the histological diagnosis, he was admitted and a brain biopsy was performed to identify the cause, with preoperative differential diagnoses including lymphomatosis cerebri
F i g u r e 2 . Re p e a t MRI t a k e n a mo n t h a f t e r t h e i n i t i a l s t u d y , s h o wi n g p r o g r e s s i o n o f t h e l e s i o n s . A, T 1 -we i g h t e d i ma g e ; B , T 2 -we i g h t e d i ma g e ; C, f l u i d -a t t e n u a t e d i n v e r s i o n r e c o v e r y i ma g e , D, d i f f u s i o n -we i g h t e d i ma g e ( DWI ) , a n d E , a p p a r e n t d i f f u s i o n c o e f f i c i e n t ( ADC) ma p . No t e t h a t t h e l es i o n s h a d mi x e d i n t e n s i t y o n DWI a n d h i g h i n t e n s i t y o n ADC ma p .
F i g u r e 3 . A p h o t o mi c r o g r a p h o f t h e s u r g i c a l s p e c i me n ( He ma t o x y l i n a n d E o s i n s t a i n i n g ) s h o wi n g a n a r e a o f a b n o r ma l l y d e n s e c e l l u l a r i t y c o n s i s t i n g o f l a r g e , a t y p i c a l c e l l s ( o r i g i n a l ma g n i f i c a t i o n : × 4 0 ) . Hi s t o l o g i c a l d i a g n o s i s o f g r a d e I I I a s t r o c y t o ma wa s ma d e .
increased, probably because of the improved survival of patients with hematological malignancies and also because of
MRI is the imaging modality of choice for the differential diagnosis of white matter lesions that develop in patients with hematological malignancies (1, 3, 6, 8) . In addition to multifocal hyperintense spots both on T2-and FLAIR sequences, hyperintensity on DWI sequence seems to be indicative of toxic leukoencephalopathy (15) . On T1-weighted image, iso-or hypointense spots may or may not be enhanced with gadolinium. In the great majority of the reported cases, the diagnosis of toxic leukoencephalopathy has been made without performing a brain biopsy. In the present patient, a brain biopsy yielded an unexpected histological finding of grade III astrocytoma. Because of its multi-lobar involvement and diffuse parenchymal invasion without creating a mass, the tumor fulfilled the diagnostic criteria of GC (11) .
Gliomatosis cerebri is a glial tumor of unknown etiology and histological origin (11, 17, 18) . There have been few cases of secondary GC that developed as a consequence of treatment for hematological malignancies in the medical literature (19) . Although secondary non-GC gliomas are known to develop in patients with hematological malignan- Re p e a t MRI o b t a i n e d 1 2 mo n t h s a f t e r i n i t i a t i o n o f t e mo z o l o mi d e , s h o wi n g s h r i n k a g 
e o f t h e l e s i o n s . A, T 2 -we i g h t e d i ma g e ; B , f l u i d -a t t e n u a t e d i n v e r s i o n r e c o v e r y i ma g e , a n d C, d i f f u s i o n -we i g h t e d i ma g e .
cies later in their course, they are associated with prior cranial irradiation almost invariably (20, 21) . With microarray gene expression profiling, several genes which might be useful in subtyping of patients with GC have been identified (22) . In the present patient, it is unlikely that prior radiation therapy for cervical NHL triggered the development of GC, because the radiation field covered only the parotid gland and cervical lymph nodes and did not cover the brain. Thus, the causal relationship between intensive chemotherapy and GC remains unclear. The unusual localization of the tumor, which seemed to be noncontiguous, also needs explanation, since typical GC spreads into multiple lobes via the corpus callosum (17, 18) . Tensor tractography may be useful in visualizing the spread of GC which may otherwise not be seen with conventional MRI sequences (23) . Temozolomide was shown to be effective in prolonging the survival in onethird of patients with GC (24 (1, 3, 6, 8) . Unlike CHOP chemotherapy (16) , toxic leukoencephalopathy associated with MACOP-B regimen has never been reported in literature (25) . Whether the MACOP-B chemotherapy is truly free of the complication remains unclear, however, since the regimen had become obsolete by early 1990s when MRI, the diagnostic modality of choice for toxic encephalopathy, became widely available to physicians (26) . Third, the lesions were depicted as mixed intensity spots on DWI and high intensity on ADC map in our patient, while typical toxic leukoencephalopathy lesions are depicted as high intensity on DWI and low intensity spots on ADC map, respectively (15, 27) . The lack of gadolinium enhancement despite rapid radiographic progression might have been another key to rule out toxic enchepahopathy. Magnetic resonance spectroscopy and positron emission tomography are promising imaging modalities that may facilitate the noninvasive differentiation of toxic leukoencephalopathy from tumorous lesions (28, 29) . Even with these sophisticated techniques, however, the radiological and histological diagnoses may contradict each other, making the case for biopsy (29) .
In summary, GC that developed in a patient with cervical NHL was reported. Brain biopsy is useful in the differential diagnosis of white matter lesions in patients with hematological malignancies whose clinical or radiographic findings are not typical for toxic leukoencephalopathy.
